Financial Performance - The company's operating revenue for 2024 reached ¥678,851,952.86, representing an increase of 18.59% compared to ¥572,438,348.90 in 2023[17]. - The net profit attributable to shareholders decreased by 32.34% to ¥15,756,018.03 in 2024 from ¥23,286,753.69 in 2023[17]. - The net profit after deducting non-recurring gains and losses fell by 51.31% to ¥8,162,379.05 in 2024 from ¥16,763,649.22 in 2023[17]. - The net cash flow from operating activities improved significantly to ¥86,249,206.64 in 2024, a 301.16% increase from -¥42,876,432.64 in 2023[17]. - The total assets at the end of 2024 were ¥1,921,788,603.80, reflecting a 3.86% increase from ¥1,850,347,745.42 at the end of 2023[17]. - The net assets attributable to shareholders increased by 3.80% to ¥1,044,372,336.21 in 2024 from ¥1,006,099,194.22 in 2023[17]. - The company reported a significant decline in basic earnings per share, which fell by 32.87% to ¥0.1879 in 2024 from ¥0.2799 in 2023[17]. - The company achieved a research and development investment of 28.33 million yuan in 2024, accounting for 4.17% of its revenue[74]. - The company reported a net profit attributable to shareholders of 1,575.60 million yuan in 2024, a decrease of 32.34% compared to the previous year[84]. - The company reported a total revenue of approximately 591.43 million for its injection mold business, with a net profit of around 22.34 million[142]. Dividend and Shareholder Information - The company plans to distribute a cash dividend of 3.00 RMB per 10 shares to all shareholders based on a total share capital of 84,757,008 shares as of December 31, 2024[4]. - The company implemented a cash dividend plan for 2023, distributing 21.63 million yuan to shareholders, which accounts for 92.89% of the 2023 net profit of 23.29 million yuan[91]. - The total shares held by the board members at the end of the reporting period increased to 43,383 shares, reflecting a change due to stock incentives[182]. - The company held a temporary shareholders' meeting on January 11, 2024, with a participation rate of 63.24%, approving several amendments to the company's articles of association and rules[180]. - The annual shareholders' meeting on May 16, 2024, had a participation rate of 62.50%, where the 2023 annual report and financial statements were approved[180]. Market and Industry Trends - In 2024, China's automotive production and sales reached 31.28 million and 31.44 million units, respectively, representing year-on-year growth of 3.7% and 4.5%[29]. - Passenger vehicle production and sales were 27.48 million and 27.56 million units, with year-on-year increases of 5.2% and 5.8%[29]. - New energy vehicle sales surpassed 10 million units for the first time, accounting for over 40% of total sales, marking a new phase of high-quality development[29]. - The automotive injection mold market in China has exceeded 50 billion RMB, with expectations for continued rapid growth in the coming years[36]. - The automotive injection mold industry is benefiting from the push for lightweight vehicles, with a projected 40% reduction in vehicle weight by 2030 compared to 2015[37]. - The demand for high-quality, low-cost, and rapid production in the automotive sector is driving the injection mold industry towards larger, more complex, and economical solutions[40]. - The automotive industry's shift towards personalization and high-end features is increasing the demand for diverse interior and exterior components, impacting mold requirements[68]. Research and Development - The company has obtained 26 invention patents and 72 utility model patents, showcasing its strong innovation capabilities in injection mold technology[74]. - The company focuses on product and technology innovation, with a robust R&D management system and collaboration with academic institutions to enhance innovation capabilities[66]. - The company is actively pursuing technological advancements in injection molding to enhance product offerings and operational efficiency[102]. - The company has completed multiple projects related to injection molding technology, with products now available in the automotive parts market, enhancing its core competitiveness[104]. - R&D personnel increased from 156 in 2023 to 164 in 2024, representing a growth of 5.13%[105]. Customer Base and Sales - The company has formed a large and stable customer base, supplying molds to renowned automotive interior and exterior parts companies such as Yanfeng, IAC, and Magna[45]. - The company has established a strong customer base, supplying molds to renowned automotive brands such as General Motors, Volkswagen, and BMW[51]. - The company sold 654 sets of automotive molds in 2024, a 33.74% increase from 489 sets in 2023, attributed to improved inventory turnover[95]. - New orders for injection molds reached 852 million yuan, a year-on-year increase of 26.97%, with total orders on hand amounting to 938 million yuan, up 22.57%[84]. Financial Management and Investments - The company has established a comprehensive supplier management system, ensuring stable relationships with key suppliers for raw material procurement[61]. - The company has implemented a refined management strategy to enhance efficiency, including upgrades to the standard parts library and the launch of a knowledge management platform to improve organizational capabilities[89]. - The company has established a foreign exchange management system to control trading risks associated with foreign exchange hedging[121]. - The company has approved the use of idle raised funds for operational activities, ensuring that the fundraising plan is implemented normally[134]. - The company has not engaged in speculative derivative investments during the reporting period[122]. Governance and Compliance - The company has established a governance structure that complies with relevant laws and regulations, ensuring the protection of shareholder interests[165]. - The board of directors consists of 7 members, including 3 independent directors, meeting legal requirements for composition[167]. - The company maintains complete independence in assets, personnel, finance, and operations from its controlling shareholders, ensuring no interference in decision-making[174]. - The company has implemented strict compliance with relevant laws and regulations during the review of significant proposals[200]. - The company actively promotes investor relations and ensures timely and accurate information disclosure to all shareholders[172].
海泰科(301022) - 2024 Q4 - 年度财报